The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Obstructive sleep apnea severity measured via apnea-hypopnea index decreased among patients receiving AD109, an oral ...

US FDA clears Hemispherian’s IND application for first-in-class glioblastoma therapeutic, GLIX1: Oslo, Norway Wednesday, August 6, 2025, 15:00 Hrs [IST] Hemispherian AS, a pione ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

Lantheus Holdings (NASDAQ:LNTH) announced on Wednesday that the U.S. Food and Drug Administration (FDA) accepted its ...

Importers can now apply, track, and receive approvals for drug consignments through an integrated digital portal, eliminating ...

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

The Council for Innovation Promotion (C4IP) today issued a statement taking Congress to task for supporting a bill introduced ...

The Trump administration is now accepting applications for a pilot program to demo rebates for 340B drugs that drugmakers ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.